Tumor suppressor alterations cooperate to drive aggressive mesotheliomas with enriched cancer stem cells via a p53-miR-34a-c-Met axis.
about
Dysregulation of the Met pathway in non-small cell lung cancer: implications for drug targeting and resistanceMerlin Isoforms 1 and 2 Both Act as Tumour Suppressors and Are Required for Optimal Sperm MaturationMicroRNAs in mesothelioma: from tumour suppressors and biomarkers to therapeutic targetsMerlin deficiency predicts FAK inhibitor sensitivity: a synthetic lethal relationshipGermline mutation of Bap1 accelerates development of asbestos-induced malignant mesothelioma.Regulation of cancer metastasis by microRNAs.Fibroblasts from patients with major depressive disorder show distinct transcriptional response to metabolic stressors.Flaxseed lignans enriched in secoisolariciresinol diglucoside prevent acute asbestos-induced peritoneal inflammation in mice.Inflammation-Related IL1β/IL1R Signaling Promotes the Development of Asbestos-Induced Malignant Mesothelioma.Mir-34: a new weapon against cancer?A subset of microRNAs defining the side population of a human malignant mesothelioma cell line.microRNA-34a as a Therapeutic Agent against Human Cancer.Synthetic Steroid Hormones Regulated Cell Proliferation Through MicroRNA-34a-5p in Human Ovarian Endometrioma.Differential regulated microRNA by wild type and mutant p53 in induced pluripotent stem cellsMicellar Delivery of miR-34a Modulator Rubone and Paclitaxel in Resistant Prostate Cancer.
P2860
Q26799900-59648EC2-7A21-4F95-A061-69B873102ECDQ27304868-D360FE5E-AE4D-4F59-BA0C-F69891075A04Q28396395-B673936F-B71A-4FB9-ABE2-8D1D9DD71CABQ34193347-2FCAA9D1-71AC-4588-BFA4-156607FCFF33Q34194566-2B2EB17B-AB99-4C36-8344-8081E81971F5Q35052860-23030195-1F0E-4A58-84B0-BF9C4C4AAE2BQ35161383-D3F99B17-D047-4C13-9F7F-E1BDCDE7F7ADQ36557014-63AD428B-1A7F-4214-A5E1-B98653AD06DBQ36863203-6C3999D1-A64D-40D1-BAE2-B076712C9E74Q38253374-84B4D375-68EB-4B02-A7A6-B3B99402ADB8Q38434033-C183165F-B611-40CF-BFD3-2B59CD8B8BE7Q38637352-7F8E661D-8726-405A-ACDA-5DEAA0CB8744Q40050612-40EFDE38-9432-428E-9941-169FE6FF874FQ41841045-F3D734CF-1564-4131-A756-676562B4220FQ47098499-B0F729D2-6FDF-4C98-ABEA-7B981900C5B8
P2860
Tumor suppressor alterations cooperate to drive aggressive mesotheliomas with enriched cancer stem cells via a p53-miR-34a-c-Met axis.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
Tumor suppressor alterations c ...... via a p53-miR-34a-c-Met axis.
@en
Tumor suppressor alterations c ...... via a p53-miR-34a-c-Met axis.
@nl
type
label
Tumor suppressor alterations c ...... via a p53-miR-34a-c-Met axis.
@en
Tumor suppressor alterations c ...... via a p53-miR-34a-c-Met axis.
@nl
prefLabel
Tumor suppressor alterations c ...... via a p53-miR-34a-c-Met axis.
@en
Tumor suppressor alterations c ...... via a p53-miR-34a-c-Met axis.
@nl
P2093
P2860
P1433
P1476
Tumor suppressor alterations c ...... via a p53-miR-34a-c-Met axis.
@en
P2093
Andres J Klein-Szanto
Craig W Menges
Deborah Altomare
Erin Neumann-Domer
Guang-Hui Xiao
Irina M Shapiro
Jacqueline Talarchek
Jonathan A Pachter
Joseph R Testa
Vihren N Kolev
P2860
P304
P356
10.1158/0008-5472.CAN-13-2062
P407
P577
2013-12-26T00:00:00Z